Ethical concerns with the use of intelligent assistive technology: findings from a qualitative study with professional stakeholders.

Journal: BMC medical ethics
PMID:

Abstract

BACKGROUND: Advances in artificial intelligence (AI), robotics and wearable computing are creating novel technological opportunities for mitigating the global burden of population ageing and improving the quality of care for older adults with dementia and/or age-related disability. Intelligent assistive technology (IAT) is the umbrella term defining this ever-evolving spectrum of intelligent applications for the older and disabled population. However, the implementation of IATs has been observed to be sub-optimal due to a number of barriers in the translation of novel applications from the designing labs to the bedside. Furthermore, since these technologies are designed to be used by vulnerable individuals with age- and multi-morbidity-related frailty and cognitive disability, they are perceived to raise important ethical challenges, especially when they involve machine intelligence, collect sensitive data or operate in close proximity to the human body. Thus, the goal of this paper is to explore and assess the ethical issues that professional stakeholders perceive in the development and use of IATs in elderly and dementia care.

Authors

  • Tenzin Wangmo
    Institute for Biomedical Ethics, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.
  • Mirjam Lipps
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Reto W Kressig
    Felix Platter Hospital, University Center for Medicine of Aging, Basel, Switzerland.
  • Marcello Ienca
    Institute for Biomedical Ethics, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland. marcello.ienca@unibas.ch.